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Background/Significance 
 
▪ Purpose: To compare the rates of phlebitis and infection rates of 
peripherally inserted intravenous catheters that are changed when 
clinically indicated rather than routinely (every 72 hours) 
 
▪ When talking to nurses:  
• Many times after a thorough IV site assessment a pt’s IV will be patent 
with blood return after 72 hours, as per hospital policy the IV will be 
removed and the pt will have a new IV placed only to no longer need 
the IV in another 24 hours.  
• Pt’s that are difficult sticks may require up to 4 attempts before 
obtaining a new IV. Extending the usage of a usable IV could save 







▪ In ICU patients, how do phlebitis and infection 
rates compare when peripherally inserted IV’s 
are changed routinely versus when clinically 
indicated?  
 
P: ICU patients with peripheral IVs  
I: Clinically indicated peripheral IV changes  
C: Routine peripheral IV changes 
O: Rates of infection and phlebitis  
TRIGGER? 
▪ Problem Focused Trigger  
• Reported frustration of nurses with frequent 
IV changes 
– Insufficient evidence to support routinely changing  
IV’s every 72 hours  
– Increased cost 
– Decreased patient satisfaction  
EVIDENCE 
▪ Search Engines:  
• EBSCOhost Research database, CINAHL, Medline, Cochrane Database 
of Systematic Reviews   
▪ Key Words:  
• Clinically indicated replacement vs. Catheter removal; Peripherally 
inserted catheter; Catheter removal and peripherally inserted central 
catheter; Catheter related infections or catheter related blood stream 
infections or catheter related complications or catheter related 
thrombosis and catheter related infections/PC and Treatment 
outcomes or nursing outcomes 
 





▪ Decreased or equal rates of phlebitis 
• Phlebitis occurred in 7% of patients with both clinically replaced IVs and 
routinely replaced IVs 
• Peripheral venous thrombophlebitis developed in 11/26 patients in the 
control group and 1/21 patients in the study group (P = 0.003). 
• Independent of study group, the rate of phlebitis and/or occlusion at 96 
hours was 23.4% (74 of 316 IVs), which was identical to the rate of 
phlebitis and/or occlusion associated with the 111 IVs used beyond 96 
hours.  
• No significant difference in phlebitis or infiltration rates in the intervention 
group(38%) compared with the control group(33%). When the analysis 
was based on failure per 1000 device days (number of failures divided by 
number of days catheterised, divided by 1000), no difference could be 
detected between the groups. The rate of phlebitis in both groups was low 
(4% in intervention group, 3% in control group). 
 
▪ Decreased or equal rates on infection 
• No significant difference between CRBSI rate. 






▪ Decreased costs 
▪ More IVDs placed per patient in the control or the routinely changed PIV 
group, with higher hospital costs per patient 
▪ Cost of cannula replacements in the control group AUD$3,837.56 
and in the intervention group was AUD$3,183.62  
▪ Infusion related costs were higher in the control group (mean 
$A41.02) than intervention group ($A36.40). 
 
▪ Increased patient satisfaction 
▪ Decreased replacements (decreased “sticks) of PIV 
 
▪ Overall decreased or equal complication rates 
▪ IVD complication rates 68 per 1,000 IVD days for clinically indicated 
replacement  and 66 per 1,000 IVD days for routine replacement 
 
▪ A thorough assessment and maintenance of PIVs can save a nurse more time in 
the long run!  
 
Current Practice at LVHN 
▪ "Peripheral short catheters sites should be 
changed every 72 hours in the adult population. 
Catheters placed in pre-hospital or institutions 
other than LVH Facilities are to be replaced 
within 24 hours of admission unless 
contraindicated. (Infusion Nursing Standard 
Practice Jan/Feb 2006. 29.  pp. S51)."      
IMPLEMENTATION (outline) 
1. Process Indicators and Outcomes  
2. Baseline Data 
3. Design (EBP) Guideline(s)/Process 
4. Implemented EBP on Pilot Units 
5. Evaluation (Post data) of Process & Outcomes 
6. Modifications to the Practice Guideline 
7. Network Implementation 
IMPLEMENTATION 
1. Indicators and Outcomes 
 
Indicators: 
▪ Adverse Affects of Routine vs. Clinically Indicated IV Changes  
▪ Patient Satisfaction of PIV Insertion and Replacements  
 
Outcome Measurements: 
▪ Patient Satisfaction   
▪ Time Saved 





2. Baseline Data Obtained In TNICU 
▪ Approximately 90% of patients have a PIV at some point during stay on unit.  
▪ Approximately 65% keep PIV throughout stay in hospital 
▪ Patient X hospitalized 90 days 
• Total IV’s 39 ( 3 IV’s pulled prior to 72hrs) 
• Estimated PIV’s needed for 72 hour changes =30 
• Estimated PIV’s needed for 95 hour changes =23 
• Average estimated cost per PIV insertion placed on initial attempt $41.00.  
• Estimated saving if PIV use extended to 96 hours ( 7 less PIV’s) $287.00. 
 
▪ According to U.S. News and World Report LVH-CC had 44,853 admissions 
in 2014. With an average estimated cost of $41.00 per PIV insertion, if 
obtained on the initial attempt. If PIV usage was extended to 96 hours and 
each admission had one less PIV’s and estimated $1,838,973 would be 
saved in one year.  
 
EBP Guidelines/Process Change 
Assessment of Peripheral 
I.V. at least every 4 hours 
No Infiltration  No Extravasation  
No Infection  
Continue to re-
assess site every 4 
hours up to 96 hours 
IMPLEMENTATION (cont.) 
4. Implemented EBP on Pilot Units 
• Project approval denied by Infectious Disease therefore unable to 
implement on TNICU 
5. Evaluation (Post data) of Process & Outcomes 
• Not applicable 
• Theoretically, based on research data no change or increase in 
infection and phlebitis rates when PIV’s are changed routinely as 
current policy dictates versus when clinically indicated per research 
6. Modifications to the Practice Guideline 
• None at this time 
7. Network Implementation 
• Continue to research data on PIV maintenance and suggested 
replacement times to present to Infectious Disease 
 
RESULTS 
• Theoretically, based on research data no 
change or increase in infection and phlebitis 
rates when PIV’s are changed routinely as 
current policy dictates versus when clinically 
indicated per research 
Implications for LVHN 
▪ This project has the potential to increase 
patient satisfaction, decrease hospital 
costs, and continue to maintain safety for 
patients in terms of infection and phlebitis 
rates related to PIV’s 
Lessons Learned 
▪Ample research and data is needed in order to obtain 
approval for changes in hospital policy 
 
▪It is difficult to change a policy that was 
implemented due to past safety issues 
• Previously, there were rises in infection and 
phlebitis rates related to PIV’s that were not 
changed routinely 
 
▪In order to implement change within the hospital, 
teamwork and cooperation are needed among 
multiple interdisciplinary groups 
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